HLA-C and cancer: In particular, the loss of binding ability to the major histocompatibility complex (MHC) in the endoplasmic reticulum (ER) is a key mechanism for immune evasion in cancer, which is usually acquired by the loss of Human Leukocyte Antigen (HLA) gene that forms MHC protein (Chowell et al. 2018).